Preserving a patient’s own teeth—even in a difficult situation—is nowadays preferable to surgical intervention and therefore promotes development of suitable dental repair materials. Biodentine®, a mineral trioxide aggregate substitute, has been used to replace dentine in a bioactive and biocompatible manner in both the dental crown and the root. The aim of our study was to evaluate the influence of Biodentine® on pulp fibroblasts in vitro. For this study, one to five Biodentine® discs with a diameter of 5.1mm were incubated in DMEM. To obtain Biodentine® suspensions the media were collected and replaced with fresh medium every 24h for 4 days. Primary pulp cells were isolated from freshly extracted wisdom teeth of 20–23 year old patients and incubated with the Biodentine® suspensions. Proliferation, cell morphology, cell integrity and cell viability were monitored. To evaluate the effect of Biodentine® on collagen type I synthesis, the secretion of the N-terminal domain of pro-collagen type I (P1NP) and the release of transforming growth factor-β1 (TGF-β1) were quantified. None of the Biodentine® suspensions tested influenced cell morphology, proliferation or cell integrity. The cell viability varied slightly depending on the suspension used. However, the concentrations of P1NP of all pulp fibroblast cultures treated for 24h with the moderate to high Biodentine® concentration containing suspensions of day 1 were reduced to 5% of the control. Furthermore, a significant TGF-β1 reduction was observed after treatment with these suspensions. It could be shown that Biodentine® is biocompatible. However, dissolved particles of the moderate to high concentrated Biodentine® suspensions 24h after mixing induce a significant reduction of TGF-β1 release and reduce the secretion of collagen type I of primary pulp fibroblasts.
Citation: Nikfarjam F, Beyer K, König A, Hofmann M, Butting M, Valesky E, et al. (2016) Influence of Biodentine® - A Dentine Substitute - On Collagen Type I Synthesis in Pulp Fibroblasts In Vitro. PLoS ONE 11(12): e0167633. https://doi.org/10.1371/journal.pone.0167633
Editor: Dimitrios Karamichos, Oklahoma State University Center for Health Sciences, UNITED STATES
Received: June 7, 2016; Accepted: November 17, 2016; Published: December 9, 2016
Copyright: © 2016 Nikfarjam et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: The authors received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Modern dental research increasingly considers teeth and oral health within the context of the whole organism [1–4] and this approach also applies to dental conservation. In the case of teeth which would have been extracted in recent years, today even time- and resource-consuming procedures are performed to conserve the original tooth rather than replacing it with pontics and implants. Therefore tissue repair, regeneration and replacement are becoming progressively more important. In this context, pulp injury presents a particular challenge. As a specific biocompatible and bioactive material for pulp injury treatment, calcium hydroxide preparations and Mineral Trioxide Aggregate (MTA) are used. Both stimulate the development of a hard-tissue seal . Since 2011, Biodentine®, a new bioactive repair and dentine-substitute containing similar components to MTA [6–8] has been available. Biodentine® is a cement-like dental material with a wide range of applications e.g. to replace the dental dentine in any part of a dental crown or root [9–11]. It consists mainly of tricalcium silicate, dicalcium silicate and calcium carbonate  dissolved in calcium chloride and polycarboxylate-containing water. Due to its phosphate cement-like consistency, exchange of ions is possible . Dentine etching  is not necessary before application. Biodentine® is in direct contact with pulp fibroblasts and therefore it is of great interest to investigate the impact of Biodentine® and its components on human pulp fibroblasts, in particular, the effect on biocompatibility and bioactivity. Collagen type I is a main component of the pulpal extracellular matrix. It accelerates mineralization and regulates gene expression  as does TGF-β1 [16, 17].
Aim of this study was to investigate the impact of Biodentine® on the physiology of isolated primary pulp fibroblasts. We could show that cell viability as well as collagen type I synthesis and TGF-β1 secretion were concentration dependently regulated.
Materials and Methods
Primary pulp fibroblasts were isolated from freshly extracted wisdom teeth of 20–23 year-old patients. Wisdom teeth were transferred directly after extraction to PBS with Ca2+, Mg2+ containing 2% penicillin/streptomycin solution (v/v) (Gibco, Karlsruhe, Germany) and 1% amphotericin solution (v/v) (Biochrome, Berlin, Germany). Thereafter they were split open and the pulp was extirpated. Pulp explant cultures were propagated in DMEM (4.5g/l glucose, Sigma-Aldrich, Schnelldorf, Germany) supplemented with 1% (v/v) penicillin/streptomycin solution, 1mM ascorbic acid 2-phosphate (Sigma-Aldrich) and 10% (v/v) fetal calf serum (PAA, Cölbe Germany). For the herein specified experiments, pulp fibroblast cultures of passages 7 to 9 were used. All studies were conducted according to the Declaration of Helsinki Principles and were approved by the Local Ethics Commission/institutional review board (IRB) of the faculty of Medicine of the Johann Wolfgang-Goethe University (Frankfurt/Main, Germany). The Local Ethic Commission/IRB waived the need for consent.
Biodentine® (Septodont, Saint-Maur-des-fossés Cedex, France, powder: tricalcium silicate, dicalcium silicate, zirconium oxide, calcium carbonate; liquid: water, calcium chloride, polycarboxylate) was reconstituted according to the manufacturer’s instructions in its capsule in a cap mix (3M ESPE Neuss, Germany) and the paste was spread on a silicon molding tool to obtain Biodentine® discs with a diameter of 5.1mm containing 0.14mg powder per disc. To obtain Biodentine® suspensions, one, three or five Biodentine® discs were incubated in 5ml of the cell-specific culture media (Table 1) containing 1% (v/v) fetal calf serum. The medium was collected and replaced every 24h. Media from 4 consecutive days were collected, centrifuged to obtain debris free suspensions and stored at -80°C.
Influence of Biodentine® on pulp fibroblasts
To evaluate the influence of the Biodentine® suspensions, cell proliferation (BrdU incorporation, mitotic index, binucleotide index, Ki-67-rate), cell viability (MTT) and cell integrity (cell morphology and lactate dehydrogenase enzyme activity assay) were monitored. Pulp fibroblasts were statistically seeded at a cell density of 1x 105 cells/ml in the above-specified DMEM if not otherwise stated in the analytical descriptions. After 24h, the culture medium was substituted with the Biodentine® suspensions, fresh culture medium with 1% (v/v) fetal calf serum (control) or medium containing 1% (v/v) Triton X-100 (Merck, Darmstadt, Germany) and incubated for a further 24h.
Morphological properties, mitotic- and binucleate index
Morphological properties as well as the mitotic- and binucleate index were monitored and analyzed after seeding pulp fibroblasts in a cell density of 1x 105 cells/ml on glass cover slips in 24 well plates (greiner bio-one, Frickenhausen, Germany). After cell adherence the culture media were substituted with the above specified Biodentine® suspensions or fresh culture medium as control. For binucleate induction cells were incubated with 1μg/ml cytochalasin B (Applichem, Darmstadt, Germany). Cell morphology was photodocumented every 2h for 24h with the incubator microscope unit IncuCyte (EssenBioScience, Hertfordshire, UK). After 24h cell were fixed with 4.5% formalin (Carl Roth, Karlsruhe, Germany) for 10min and washed with PBS++. Thereafter cell nuclei were counterstained with DAPI (Roche, Mannheim, Germany). Photographs were taken with a digital camera (Sony Cyber Shot 3.3, Sony, Cologne, Germany) connected to a Zeiss Axioskop (Zeiss, Oberkochen, Germany). The mitotic index and binucleate index were determined evaluating the number of cells showing mitotic phases (pro-metaphase to telophase) or binucleates (S1 Fig). Per condition and culture 1000 to 1089 cells were blindly analyzed.
Pulp fibroblasts were seeded in a cell density of 5x105 cell/ml. The medium was substituted on the following day as described above. After 24h cells were detached from the cell culture surface and fixed in 70% ethanol (Applichem) for at least 2h at -20°C. Thereafter the cells were washed with PBS containing 1% fetal calf serum. Cells were stained with either the monoclonal mouse anti-human Ki67, Alexa Fluor 647 conjugated (BD Biosciences Cat# 561126, RRID:AB_10611874) or the isotype control mouse IgG1, κ, Alexa Fluor 647 conjugated, Clone MOPC-21 (BD Biosciences Cat# 557714, RRID:AB_396823) according to the manufacturer’s instructions for 30min at room temperature. After washing twice with PBS containing 1% fetal calf serum to eliminate unbound antibodies, cell suspensions were incubated for 1h at 4°C with propidium iodide (Sigma-Aldrich). Cell suspensions were analyzed with an Accuri C6 flowcytometer (BD Biosciences, Heidelberg, Germany).
The proliferative potential was analyzed with the Cell Proliferation ELISA BrdU (5-Brom-2‘-desoxyuridin, Roche, Mannheim, Germany) according to the manufacturer’s instructions. The test principal relies on the incorporation of BrdU during DNA replication as thymidine base analogue. Therefore the amount of BrdU incorporation can be used as analytical parameter for cell proliferation. The absorptions were measured with an ELISA-Reader (ASYS Expert 96, Biochrom, Cambridge, UK).
Cell viability and cell integrity
Cell viability was evaluated using the MTT Cell Proliferation Assay (Trevigen, Gaithersburg, USA). The yellow tetrazolium salt is intracellularly reduced to purple formazan. After cell-lysis the amount of formazan can be measured. As analytical parameter for loss of cell integrity the cytosolic lactate dehydrogenase was chosen. The enzyme activity in cell free supernatants was measured with the Cytotoxicity Detection Assay (LDH, Roche). All assays were performed according to the manufacturers’ instructions and absorptions were measured with an ELISA-Reader.
Collagen type I synthesis
To evaluate the effect of Biodentine® on collagen type I synthesis, the concentration of the N-terminal domain of pro-collagen type I (P1NP) was quantified with the P1NP-Assay (P1NP-Elecsys assay, Roche Pharmaceuticals, Grenzach-Wyhlen, Germany) according to the manufacturer’s instructions as described . Pulp fibroblasts were seeded at a cell density of 5x104 cells/ml in 24-well plates. After 24h the culture medium was substituted either by fresh medium or by the above specified suspensions of Biodentine®. Additionally the high concentrated Biodentine® suspension of day 1 was serially diluted (Table 2) before being added to the pulp fibroblast cultures. Cell-free supernatants were collected after 24h incubation with the respective media. P1NP was quantified.
Enzyme-linked immunosorbent assay of TGF-β1
To determine the influence of Biodentine® suspensions on TGF-β1 secretion, pulp fibroblasts were seeded and treated as described above. Cell-free supernatants were assayed using a commercial ELISA test kit (R&D, Wiesbaden-Nordenstadt, Germany) according to the manufacturer’s protocol.
Immunhistochemical analysis of pulp fibroblasts
Pulp fibroblasts were seeded in a cell density of 5x 104 cells/ml on glass cover slides. On the following day the cultures were treated with the Biodentine® suspensions for 24h. Cultures destined for collagen type I staining were fixed in acetone for 10min at -20°C, cultures destined for TGF-β1 staining were fixed in 4% paraformaldehyd (Carl Roth) for 10min at room temperature. Thereafter the cultures were washed three times with PBS before blocking with 3% (v/v) bovine serum (Carl Roth) for 90min. After washing with PBS including 0.2% Tween (v/v) (Applichem) cells were stained overnight at 4°C with 1:500 diluted polyclonal rabbit anti-human collagen type 1 (Abcam Cat# ab34710, RRID:AB_731684) or 1:50 diluted monoclonal mouse anti-human TGF-β1 (Abcam Cat# ab27969, RRID:AB_778340). As secondary antibodies we used 1:500 diluted polyclonal goat anti-rabbit IgG (H+L), Alexa Fluor 546 conjugated (Thermo Fisher Scientific, Rockford USA, Cat# A-11010, RRID:AB_2534077) or polyclonal goat anti-mouse IgG (H+L), Alexa Fluor 546 conjugated (Thermo Fisher Scientific Cat# A-11003, RRID:AB_2534071) and incubated for 1h at room temperature. After washing the cells with 0.2% Tween PBS cell nuclei were counterstained with DAPI (Thermo Fisher Scientific) for 10min at room temperature and washed briefly in PBS and demineralised water. Coverslips were covered with Aqua Poly Mount (Polysciences, Hirschberg an der Bergstrasse, Germany) and fixed on microscope slides. Photographs were taken with a digital camera (Sony Cyber Shot 3.3, Sony, Cologne, Germany) connected to a Olympus BX-50 (Olympus, Hamburg, Germany). Fluorescence intensity of the collagen type I and TGF-β1 staining was quantified with Image J .
Presentation of data and statistical analysis
All data are presented as mean values ± standard deviation of duplicates (Ki-67 analysis), triplicates (mitotic index, binucleate index), quadruplicate replicates (P1NP, TGF-β1) or sextuplicate replicates (BrdU, MTT, LDH). Statistical significance was evaluated by the Wilcoxon-Mann-Whitney U-test (BIAS, Frankfurt, Germany). Each set of data was related to the referring untreated control. Differences were considered significant at * p≤0.05; ** p≤0.01; *** p≤0.001. For significant differences between samples the magnitude of effect was calculated according to Rosenthal  (BIAS). E≥0.1 represents small effects, E≥0.3 represents moderate effects and E≥0.5 represents high effects (S1–S5 Tables).
Biodentine® is used as a dentine substitute in restorative dental therapy and as a capping agent in dentistry [21–23]. To characterize the effects caused by this tricalcium silicate based cement, primary pulp fibroblasts were treated for 24h with different Biodentine® suspensions. Elucidating concentration dependent effects (low, moderate and high Biodentine® concentrations) and time-dependent effects (harvesting of the suspensions every 24h on 4 consecutive days) were achieved by incubation of pulp fibroblasts with the individual suspensions.
Biodentine® suspensions do not influence cell integrity or cell morphology of pulp fibroblasts
It could be shown that the morphology of the pulp fibroblasts treated with low (Fig 1C and 1D), moderate (Fig 1E and 1F) or high (Fig 1G and 1H) concentrated Biodentine® suspensions did not differ from control cultures (Fig 1A and 1B) neither initially (Fig 1A, 1C, 1E and 1G) nor after 24h (Fig 1B, 1D, 1F and 1H). Furthermore it could be shown that the LDH activity (Fig 2A) in the cell free supernatants of cultures treated with suspensions of low (dotted bar), moderate (striped bar) or high (bricked bar) Biodentine® concentrations was not increased or reduced in comparison to the control (white bar). As a positive control, pulp fibroblasts were treated with 1% Triton X-100 (black bar). The LDH activity of these samples was 200% higher than the control.
Cell morphology was monitored with an incubator microscope unit. Shown are exemplary pictures of the cell morphology immediately after application of the Biodentine® suspensions or fresh control medium (A,C,E,G) and after 24h (B,D,F,H). Morphological changes could not be observed between the control (A,B) and the Biodentine® suspensions of low (C,D), moderate (E,F) or high (G,H) concentration.
Cell integrity was monitored by assaying LDH activity (A; N = 324). No influence by the Biodentine® suspensions of low (dotted bar), moderate (striped bar) or high (bricked bar) Biodentine® concentrations on LDH activity could be observed in comparison to the control (white bar). LDH activity of the Triton X-100 (black bar) treated cultures was significantly increased. Biodentine® suspensions containing low Biodentine® concentrations increased cell viability whereas suspensions containing high Biodentine® concentrations reduced cell viability (B; N = 270). The data displayed are representative of three independent experiments performed with comparable results. Average absorbance values (mean ± SD) from n = 6 replicates per experimental condition were calculated. * p ≤ 0.05; ** p≤0.01.
Biodentine® suspensions influence cell viability concentration and time dependently
Biodentine® suspensions influence cell viability diversely. When incubating pulp fibroblasts with the suspensions containing low Biodentine® concentrations, cell viability was increased by up to 46% of the control (Fig 2B). Monitoring cell viability after treatment with the suspensions containing moderate Biodentine® concentrations showed no impact on pulp fibroblasts compared to the control whereas a distinct cell viability reduction could be observed in the case of treatment of pulp fibroblasts with the suspensions containing high Biodentine® concentrations on day 1. The remaining suspensions containing high Biodentine® concentrations had no impact on cell viability.
Biodentine® suspensions do not influence proliferation
Analysing the influence of the different Biodentine® suspensions concerning proliferation revealed that none of the suspensions used influenced the incorporation of BrdU during S-phase (Fig 3A) or the amount of Ki-67 positive cells (Fig 3B) significantly. To further validate this observation the mitotic index (Fig 4A) and the binucleotide index (Fig 4B) were determined. The number of cells showing characteristic mitotic phases (S1A–S1D Fig) were correlated to the total cell number for the mitotic index. For the binucleate index the cell number showing two nuclei (S1E and S1F Fig) after inhibiting cytokinesis by cytochalasin B were correlated to the total cell number. Neither index showed significant differences between the controls and the Biodentine® suspension treated pulp fibroblast cultures.
Neither the incorporation of BrdU (A; N = 270) nor the number of Ki-67 positive cells (B) was significantly influenced by the Biodentine® suspensions of low (dotted bar), moderate (striped bar) or high (bricked bar) Biodentine® concentrations in comparison to the control (white bar). The data displayed are representative of three independent experiments (BrdU) or two independent experiments (Ki-67) performed with comparable results. Average absorbance values (mean ± SD) from n = 6 replicates per experimental condition calculated for the BrdU assay and the percental amount of Ki67-positive cells correlated to the control are shown.
The amount of cells showing characteristic mitotic phases (A) or binucleates (B) was correlated to the total cell number analyzed per treatment condition. No differences could be observed between the Biodentine® suspensions of low (dotted bar), moderate (striped bar) or high (bricked bar) Biodentine® or the controls (white bar). The data displayed are representative of three independent experiments performed with comparable results. For each culture condition approximately 1.000 cells were evaluated.
Biodentine® suspensions decrease collagen type I synthesis and TGF-β1 secretion in pulp fibroblasts
After revealing that cell viability was influenced by the Biodentine® suspensions, the influence on collagen synthesis was investigated. Pulp fibroblasts were incubated with low, moderate or high Biodentine® concentration containing suspensions. Whereas none of the suspension preparations containing low Biodentine® concentrations influenced the concentration of P1NP and therefore collagen type I synthesis, the suspensions of day 1 of the preparations containing moderate or high Biodentine® concentrations reduced collagen type I synthesis to 5% of the control (Fig 5A). The collagen type I synthesis reduction is limited to the suspension preparations of day 1. To verify these results the suspension preparations of day 1 containing high Biodentine® concentrations were serially diluted before treating pulp fibroblasts. It could be shown that collagen type I synthesis was reduced up to a dilution factor of 1.75, but was comparable to the controls thereafter (Fig 5B). Immunhistochemical staining of collagen type I (Fig 6) revealed that no differences between the controls (Fig 6A and 6B) and the cultures incubated with suspensions containing low (C,D) to medium (E,F) Biodentine® concentrations of day 1 and day 2 could be observed. After incubating pulp cells with high Biodentine® concentrations a slightly more intense collagen type I staining could be observed in the region of the cell nucleus while the intensity in the cell periphery was lower than in all other cultures. Quantitative evaluation of the fluorescence intensity (Fig 7A) of the collagen type I staining revealed that the suspensions containing low Biodentine® concentrations of day 2 and the suspensions containing high Biodentine® concentrations of day 1 and day 2 showed significantly lower fluorescence intensities than the other cultures.
Collagen type I synthesis was evaluated measuring P1NP concentrations of cultures left untreated (white bar) or treated with Biodentine® suspensions of low (dotted bar), moderate (striped bar) or high (bricked bar) Biodentine® concentrations. P1NP in pulp cells treated with the Biodentine® suspensions of day 1 was severely reduced (A; N = 180). Serial dilutions of the high Biodentine® concentrations containing suspensions of day 1 revealed that up to a serial dilution of 1.75, P1NP secretion was reduced whereas dilutions from 2.5 did not influence P1NP secretion (B; N = 84). The data displayed are representative of three independent experiments performed with comparable results. Average absorbance values (mean ± SD) from n = 4 replicates per experimental condition were calculated. * p ≤ 0.05.
The collagen type I synthesis of pulp fibroblasts treated with normal culture medium (A,B), Biodentine® suspensions of low (C,D), moderate (E,F) or high (G,H) Biodentine® concentrations of day 1 (A,C,E,G) or day 2 (B,D,F,H) were immunhistochemically monitored.
Collagen type I (A) and TGF-β1 (B) concentrations were measured by quantifying the fluorescence intensities of the respective immunhistochemical stainings of cultures treated with Biodentine® suspensions of low (dotted bar), moderate (striped bar) or high (bricked bar) Biodentine® concentrations in comparison to control cultures (white bar). The data displayed are representative of two independent experiments performed with comparable results. Average fluorescence intensity per cell (mean ± SD) from 14 to 17 individual cells per experimental condition were calculated. * p ≤ 0.05; *** p ≤ 0.001.
Considering the importance of TGF-β1 for collagen synthesis as well as pulp regeneration, the influence of Biodentine® suspensions on TGF-β1 secretion and distribution within the pulp fibroblasts (S2 Fig) was monitored. Pulp fibroblasts were treated according to the treatment regime for collagen type I synthesis. A clear concentration-dependent reduction of TGF-β1 concentration (Fig 7B) within the pulp fibroblasts could be observed after quantitative evaluation of the fluorescence intensity of the immunhistochemical stainings. Furthermore it could be shown that TGF-β1 secretion was reduced by incubation of the cells with the Biodentine® preparations of day 1 (Fig 8A). Analysing TGF-β1 concentrations of the dilutions of the preparations of day 1 containing high Biodentine® concentrations confirmed that Biodentine® reduced TGF-β1 secretion concentration dependently (Fig 8B).
TGF-β1 secretion was evaluated with a TGF-β1 ELISA. It could be shown that the Biodentine® suspensions of low (dotted bar), moderate (striped bar) or high (bricked bar) Biodentine® concentrations of day 1 reduced the TGF-β1 secretion in a concentration dependent way (A; N = 180) in comparison to the control (white bar). Serial dilutions of the high Biodentine® concentrations containing suspensions of day 1 substantiated the concentration dependent TGF-β1 secretion inhibition (B; N = 84). The data displayed are representative of three independent experiments that were performed with comparable results. Average absorbance values (mean ± SD) from n = 4 replicates per experimental condition were calculated. * p ≤ 0.05.
Exposition of pulp fibroblasts to Biodentine® in our experimental setting revealed that none of the used suspensions influenced cell morphology or cell integrity according to the microscopic images and the quantification of the LDH activity. Although for similar components containing MTA, anti-proliferative [24, 25] as well as pro-proliferative effects  have been described, we could not determine any influence on proliferation. The inconsistent influence might be related to different cell species used or the different analytical parameters chosen for evaluating the proliferative potential of the analyzed dentine substitutes. In our study we did not determine the cell number or the time span to cover an artificially generated wound area but determined the amount of incorporated BrdU, the mitotic index as well as the development of binucleates after inhibiting cytokinesis. All of these aspects are dependent on cells performing mitosis. Coverage of an artificial wound is always associated to cell division but also to migratory processes. In vitro as well as in vivo Ki-67 is often used as a proliferative marker [27–30] because it is not expressed in G0 but in all other mitotic cell cycle phases. Our investigations showed that this parameter was also not significantly altered by Biodentine® treatment. The viability of pulp cells increased when exposed to highly diluted Biodentine® suspensions and decreased in a concentration-dependent manner. Similar effects have already been described for different cell species [26, 31–35] also considering time dependent effects . Apart from biocompatibility, we were interested investigating the influence on the main component of the pulpal extracellular matrix. Collagen type I expression has been described to have a direct effect on hard dental tissue generation and mineralization [37, 38]. The influence of Biodentine® and MTA on extracellular matrix proteins is versatile. It has been shown in a murine pulp cell line (OD21)  and human dental pulp cells  that calcium silicate containing materials decrease collagen type I mRNA expression [41, 42]. In our studies we could show that the described reduced collagen mRNA level correlates well with our collagen type I protein concentration analysis. Furthermore it has been described that Biodentine® as wells as MTA induced collagen fibre degradation . In contrast to our observations increased collagen synthesis [44–46] and faster formation of new dentine [23, 47, 48] and induction of osteogenesis  have been described for calcium silicate cements. A reason for the versatile observations might be that the concentrations of Biodentine® and/or the surface area exposed to culture media is not consistent in the described studies. In our study e.g. we investigated surface contact areas per ml medium from 14,58mm2 to 70.92mm2 and therefore defined low Biodentine® concentration as 14.58mm2 whereas Laurent et al. investigated contact surface areas of 0,05mm2 to 50mm2 . Acknowledging the significance of TGF-β1 not only on collagen type I  synthesis but also on pulp regeneration in general [50, 52, 53], we could show that moderate to highly concentrated Biodentine® suspensions reduced the initial TGF-β1 secretion. However, low Biodentine® concentrations seem to induce TGF-β1 secretion as well as other growth factors [50, 54–56]. In our study serial dilutions of the highest Biodentine® suspension substantiated the concentration-dependent effects on collagen type I synthesis and TGF-β1 secretion. We are therefore of the opinion that the TGF-β1 secretion decrease is responsible for the observed collagen type I synthesis reduction. Time and material specific differences of TGF-β secretion have been described showing that the secretion in the Portland cement group was higher than in the MTA treated group .
The present study is consistent with previous studies showing biocompatibility of Biodentine®. The clinical implication of the herein reported short term reduction of collagen type I synthesis has not been reported yet. Even though the influence of MTA and Biodentine® on the generation of extracellular matrix proteins has been investigated in a variety of cell species involved in dentine regeneration contradictory influences showing stimulatory as wells as inhibitory effects have been reported. Clinical observations predominantly report induction of restorative tissue formation for tricalcium silicate cements. Due to the fact that Biodentine® shows comparable physical and clinical qualities to MTA secondary criteria e.g. facilitated handling, applicability and faster setting time are taken into account.
Evaluation of the observed effects remains to be elucidated in comparison to other dentine substitutes as well as in other primary cell cultures and/or in in vitro three-dimensional tissue cultures
S1 Fig. Exemplary pictures for identification of mitotic and binucleate cells.
To determine the mitotic index after Biodentine® suspension exposure cell nuclei showing characteristics of pro-metaphase to anaphase (A-D) were counted. The number of cells showing two cell nuclei after inhibiting cytokinesis by cytochalasin B (E, F) was used to define the binucleate index.
S2 Fig. Exemplary pictures of TGF-β1 staining after incubation with Biodentine® suspensions.
TGF-β1 distribution in pulp fibroblasts treated with normal culture medium (A) Biodentine® suspensions of low (B), moderate (C) or high (D) Biodentine® concentrations of day 1 was immunhistochemically monitored.
S1 Table. Detailed statistical information of the lactate dehydrogenase activity after Biodentine® exposure.
S2 Table. Detailed statistical information of cell viability analysis after Biodentine® exposure.
S3 Table. Detailed statistical information of the collagen type I synthesis after Biodentine® exposure.
S4 Table. Detailed statistical information of the collagen type I and TGF-β1 staining after Biodentine® exposure.
The authors are grateful to Wendy Stevens and Dr. Adrian Sewell for comments and discussion.
- Conceptualization: SK RK DH AB NZ.
- Data curation: FN EV NZ.
- Formal analysis: FN MH NZ.
- Funding acquisition: SK RK AB NZ.
- Investigation: FN KB AK MB NZ.
- Methodology: FN SK AB NZ.
- Project administration: SK AB NZ.
- Resources: SK RK DH AB NZ.
- Supervision: SK AB NZ.
- Validation: FN EV NZ.
- Visualization: FN NZ.
- Writing – original draft: FN NZ.
- Writing – review & editing: EV SK NZ.
- 1. Koziel J, Mydel P, Potempa J. The link between periodontal disease and rheumatoid arthritis: an updated review. Current rheumatology reports. 2014;16(3):408. Epub 2014/01/25. pmid:24458478
- 2. Aleksova P, Serafimoski V, Popovska M, Ristovski M. Pulp stones can help in detection of calculus in the kidneys and/or in the bile--fact or fiction? Prilozi / Makedonska akademija na naukite i umetnostite, Oddelenie za bioloski i medicinski nauki = Contributions / Macedonian Academy of Sciences and Arts, Section of Biological and Medical Sciences. 2013;34(2):159–67. Epub 2013/11/28.
- 3. Blum IR, Lynch CD, Schriever A, Heidemann D, Wilson NH. Repair versus replacement of defective composite restorations in dental schools in Germany. Eur J Prosthodont Restor Dent. 2011;19(2):56–61. Epub 2011/07/26. pmid:21780727
- 4. Mayard-Pons ML, Rilliard F, Libersa JC, Musset AM, Farge P. Database analysis of a French type 2 diabetic population shows a specific age pattern of tooth extractions and correlates health care utilization. J Diabetes Complications. 2015;29(8):993–7. Epub 2015/10/16. pmid:26463898
- 5. Bidar M, Naghavi N, Mohtasham N, Sheik-Nezami M, Fallahrastegar A, Afkhami F, et al. Mineral trioxide aggregate and portland cement for direct pulp capping in dog: a histopathological evaluation. Journal of dental research, dental clinics, dental prospects. 2014;8(3):134–40. Epub 2014/10/28. pmid:25346831
- 6. Torabinejad M, Parirokh M. Mineral trioxide aggregate: a comprehensive literature review--part II: leakage and biocompatibility investigations. Journal of endodontics. 2010;36(2):190–202. Epub 2010/02/02. pmid:20113774
- 7. Poggio C, Ceci M, Dagna A, Beltrami R, Colombo M, Chiesa M. In vitro cytotoxicity evaluation of different pulp capping materials: a comparative study. Arh Hig Rada Toksikol. 2015;66(3):181–8. Epub 2015/10/09. pmid:26444338
- 8. Utneja S, Nawal RR, Talwar S, Verma M. Current perspectives of bio-ceramic technology in endodontics: calcium enriched mixture cement—review of its composition, properties and applications. Restorative dentistry & endodontics. 2015;40(1):1–13. Epub 2015/02/12.
- 9. Cuadros-Fernandez C, Lorente Rodriguez AI, Saez-Martinez S, Garcia-Binimelis J, About I, Mercade M. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial. Clinical oral investigations. 2015. Epub 2015/11/19.
- 10. Niranjani K, Prasad MG, Vasa AA, Divya G, Thakur MS, Saujanya K. Clinical Evaluation of Success of Primary Teeth Pulpotomy Using Mineral Trioxide Aggregate((R)), Laser and Biodentine(TM)- an In Vivo Study. Journal of clinical and diagnostic research: JCDR. 2015;9(4):ZC35–7. Epub 2015/05/30. pmid:26023640
- 11. Nayak G, Hasan MF. Biodentine-a novel dentinal substitute for single visit apexification. Restorative dentistry & endodontics. 2014;39(2):120–5. Epub 2014/05/03.
- 12. Malkondu O, Karapinar Kazandag M, Kazazoglu E. A review on biodentine, a contemporary dentine replacement and repair material. BioMed research international. 2014;2014:160951. Epub 2014/07/16. pmid:25025034
- 13. Villat C, Tran XV, Pradelle-Plasse N, Ponthiaux P, Wenger F, Grosgogeat B, et al. Impedance methodology: A new way to characterize the setting reaction of dental cements. Dental materials: official publication of the Academy of Dental Materials. 2010;26(12):1127–32. Epub 2010/08/24.
- 14. Raskin A, Eschrich G, Dejou J, About I. In vitro microleakage of Biodentine as a dentin substitute compared to Fuji II LC in cervical lining restorations. The journal of adhesive dentistry. 2012;14(6):535–42. Epub 2012/06/23. pmid:22724110
- 15. Mizuno M, Miyamoto T, Wada K, Watatani S, Zhang GX. Type I collagen regulated dentin matrix protein-1 (Dmp-1) and osteocalcin (OCN) gene expression of rat dental pulp cells. J Cell Biochem. 2003;88(6):1112–9. Epub 2003/03/21. pmid:12647294
- 16. Tziafas D, Alvanou A, Papadimitriou S, Gasic J, Komnenou A. Effects of recombinant basic fibroblast growth factor, insulin-like growth factor-II and transforming growth factor-beta(1) on dog dental pulp cells in vivo. Arch Oral Biol. 1998;43(6):431–44. pmid:9717581
- 17. Widbiller M, Eidt A, Hiller KA, Buchalla W, Schmalz G, Galler KM. Ultrasonic activation of irrigants increases growth factor release from human dentine. Clinical oral investigations. 2016. Epub 2016/04/27.
- 18. Zöller NN, Kippenberger S, Thaci D, Mewes K, Spiegel M, Sattler A, et al. Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model. Toxicology in vitro: an international journal published in association with BIBRA. 2008;22(3):747–59. Epub 2008/02/06.
- 19. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–5. pmid:22930834
- 20. Rosenthal R. Meta-Analytic Procedures for Social Research: SAGE Publications; 1991.
- 21. Nowicka A, Wilk G, Lipski M, Kolecki J, Buczkowska-Radlinska J. Tomographic Evaluation of Reparative Dentin Formation after Direct Pulp Capping with Ca(OH)2, MTA, Biodentine, and Dentin Bonding System in Human Teeth. Journal of endodontics. 2015;41(8):1234–40. Epub 2015/06/03. pmid:26031301
- 22. Kenchappa M, Gupta S, Gupta P, Sharma P. Dentine in a capsule: clinical case reports. J Indian Soc Pedod Prev Dent. 2015;33(3):250–4. Epub 2015/07/15. pmid:26156282
- 23. Kim J, Song YS, Min KS, Kim SH, Koh JT, Lee BN, et al. Evaluation of reparative dentin formation of ProRoot MTA, Biodentine and BioAggregate using micro-CT and immunohistochemistry. Restorative dentistry & endodontics. 2016;41(1):29–36. Epub 2016/02/16.
- 24. Willershausen I, Wolf T, Kasaj A, Weyer V, Willershausen B, Marroquin BB. Influence of a bioceramic root end material and mineral trioxide aggregates on fibroblasts and osteoblasts. Arch Oral Biol. 2013;58(9):1232–7. Epub 2013/05/08. pmid:23647932
- 25. Michel A, Erber R, Frese C, Gehrig H, Saure D, Mente J. In vitro evaluation of different dental materials used for the treatment of extensive cervical root defects using human periodontal cells. Clinical oral investigations. 2016.
- 26. Cornelio AL, Rodrigues EM, Salles LP, Mestieri LB, Faria G, Guerreiro-Tanomaru JM, et al. Bioactivity of MTA Plus, Biodentine and experimental calcium silicate-based cements in human osteoblast-like cells. International endodontic journal. 2015. Epub 2015/11/27.
- 27. Soydan SS, Araz K, Senel FV, Yurtcu E, Helvacioglu F, Dagdeviren A, et al. Effects of alendronate and pamidronate on apoptosis and cell proliferation in cultured primary human gingival fibroblasts. Hum Exp Toxicol. 2015;34(11):1073–82. pmid:25636638
- 28. Guven G, Gunhan O, Akbulut E, Cehreli ZC. Investigation of proliferative activity in the developing human tooth using Ki-67 immunostaining. Med Princ Pract. 2007;16(6):454–9. pmid:17917446
- 29. Dujic J, Kippenberger S, Ramirez-Bosca A, Diaz-Alperi J, Bereiter-Hahn J, Kaufmann R, et al. Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model. International journal of cancer Journal international du cancer. 2009;124(6):1422–8. Epub 2008/11/28. pmid:19035461
- 30. Muica Nagy-Bota MC, Pap Z, Denes L, Ghizdavat A, Brinzaniuc K, Lup Cosarca AS, et al. Immunohistochemical study of Ki67, CD34 and p53 expression in human tooth buds. Rom J Morphol Embryol. 2014;55(1):43–8. Epub 2014/04/10. pmid:24715164
- 31. Lee BN, Son HJ, Noh HJ, Koh JT, Chang HS, Hwang IN, et al. Cytotoxicity of newly developed ortho MTA root-end filling materials. Journal of endodontics. 2012;38(12):1627–30. Epub 2012/11/14. pmid:23146650
- 32. Poggio C, Ceci M, Beltrami R, Dagna A, Colombo M, Chiesa M. Biocompatibility of a new pulp capping cement. Ann Stomatol (Roma). 2014;5(2):69–76. Epub 2014/07/09.
- 33. Khedmat S, Dehghan S, Hadjati J, Masoumi F, Nekoofar MH, Dummer PM. In vitro cytotoxicity of four calcium silicate-based endodontic cements on human monocytes, a colorimetric MTT assay. Restorative dentistry & endodontics. 2014;39(3):149–54. Epub 2014/08/12.
- 34. Lee BN, Lee KN, Koh JT, Min KS, Chang HS, Hwang IN, et al. Effects of 3 endodontic bioactive cements on osteogenic differentiation in mesenchymal stem cells. Journal of endodontics. 2014;40(8):1217–22. Epub 2014/07/30. pmid:25069936
- 35. Kucukkaya S, Gorduysus MO, Zeybek ND, Muftuoglu SF. In Vitro Cytotoxicity of Calcium Silicate-Based Endodontic Cement as Root-End Filling Materials. Scientifica. 2016;2016:9203932. Epub 2016/02/24. pmid:26904364
- 36. E AS, Farhadmollashahi N, Ghotbi F, Karkeabadi H, Havaei R. Cytotoxic effects of mineral trioxide aggregate, calcium enrichedmixture cement, Biodentine and octacalcium pohosphate onhuman gingival fibroblasts. Journal of dental research, dental clinics, dental prospects. 2016;10(2):75–80. Epub 2016/07/19. pmid:27429722
- 37. Helder MN, Bronckers AL, Woltgens JH. Dissimilar expression patterns for the extracellular matrix proteins osteopontin (OPN) and collagen type I in dental tissues and alveolar bone of the neonatal rat. Matrix. 1993;13(5):415–25. Epub 1993/09/01. pmid:8246837
- 38. Andujar MB, Couble P, Couble ML, Magloire H. Differential expression of type I and type III collagen genes during tooth development. Development. 1991;111(3):691–8. Epub 1991/03/01. pmid:1879336
- 39. Zanini M, Sautier JM, Berdal A, Simon S. Biodentine induces immortalized murine pulp cell differentiation into odontoblast-like cells and stimulates biomineralization. Journal of endodontics. 2012;38(9):1220–6. Epub 2012/08/16. pmid:22892739
- 40. Oncel Torun Z, Torun D, Demirkaya K, Yavuz ST, Elci MP, Sarper M, et al. Effects of iRoot BP and white mineral trioxide aggregate on cell viability and the expression of genes associated with mineralization. International endodontic journal. 2015;48(10):986–93. Epub 2014/10/08. pmid:25286824
- 41. Widbiller M, Lindner SR, Buchalla W, Eidt A, Hiller KA, Schmalz G, et al. Three-dimensional culture of dental pulp stem cells in direct contact to tricalcium silicate cements. Clinical oral investigations. 2016;20(2):237–46. Epub 2015/07/01. pmid:26121971
- 42. Perard M, Le Clerc J, Watrin T, Meary F, Perez F, Tricot-Doleux S, et al. Spheroid model study comparing the biocompatibility of Biodentine and MTA. Journal of materials science Materials in medicine. 2013;24(6):1527–34. Epub 2013/03/22. pmid:23515903
- 43. Leiendecker AP, Qi YP, Sawyer AN, Niu LN, Agee KA, Loushine RJ, et al. Effects of calcium silicate-based materials on collagen matrix integrity of mineralized dentin. Journal of endodontics. 2012;38(6):829–33. pmid:22595120
- 44. Hakki SS, Bozkurt SB, Ozcopur B, Purali N, Belli S. Periodontal ligament fibroblast response to root perforations restored with different materials: a laboratory study. International endodontic journal. 2012;45(3):240–8. Epub 2011/10/20. pmid:22007644
- 45. Du R, Wu T, Liu W, Li L, Jiang L, Peng W, et al. Role of the extracellular signal-regulated kinase 1/2 pathway in driving tricalcium silicate-induced proliferation and biomineralization of human dental pulp cells in vitro. Journal of endodontics. 2013;39(8):1023–9. Epub 2013/07/25. pmid:23880270
- 46. Pelliccioni GA, Ciapetti G, Cenni E, Granchi D, Nanni M, Pagani S, et al. Evaluation of osteoblast-like cell response to Proroot MTA (mineral trioxide aggregate) cement. Journal of materials science Materials in medicine. 2004;15(2):167–73. Epub 2004/08/28. pmid:15330052
- 47. Fayazi S, Ostad SN, Razmi H. Effect of ProRoot MTA, Portland cement, and amalgam on the expression of fibronectin, collagen I, and TGFbeta by human periodontal ligament fibroblasts in vitro. Indian J Dent Res. 2011;22(2):190–4. Epub 2011/09/06. pmid:21891883
- 48. Rathinam E, Rajasekharan S, Chitturi RT, Martens L, De Coster P. Gene Expression Profiling and Molecular Signaling of Dental Pulp Cells in Response to Tricalcium Silicate Cements: A Systematic Review. Journal of endodontics. 2015;41(11):1805–17. Epub 2015/09/19. pmid:26381895
- 49. Margunato S, Tasli PN, Aydin S, Karapinar Kazandag M, Sahin F. In Vitro Evaluation of ProRoot MTA, Biodentine, and MM-MTA on Human Alveolar Bone Marrow Stem Cells in Terms of Biocompatibility and Mineralization. Journal of endodontics. 2015;41(10):1646–52. pmid:26410417
- 50. Laurent P, Camps J, About I. Biodentine(TM) induces TGF-beta1 release from human pulp cells and early dental pulp mineralization. International endodontic journal. 2012;45(5):439–48. Epub 2011/12/23. pmid:22188368
- 51. Strong DD, Beachler AL, Wergedal JE, Linkhart TA. Insulinlike growth factor II and transforming growth factor beta regulate collagen expression in human osteoblastlike cells in vitro. J Bone Miner Res. 1991;6(1):15–23. Epub 1991/01/01. pmid:1710867
- 52. Begue-Kirn C, Smith AJ, Ruch JV, Wozney JM, Purchio A, Hartmann D, et al. Effects of dentin proteins, transforming growth factor beta 1 (TGF beta 1) and bone morphogenetic protein 2 (BMP2) on the differentiation of odontoblast in vitro. The International journal of developmental biology. 1992;36(4):491–503. Epub 1992/12/01. pmid:1295560
- 53. Howard C, Murray PE, Namerow KN. Dental pulp stem cell migration. Journal of endodontics. 2010;36(12):1963–6. Epub 2010/11/26. pmid:21092813
- 54. Peters OA, Galicia J, Arias A, Tolar M, Ng E, Shin SJ. Effects of two calcium silicate cements on cell viability, angiogenic growth factor release, and related gene expression in stem cells from the apical papilla. International endodontic journal. 2015. Epub 2015/11/06.
- 55. Tomson PL, Lumley PJ, Smith AJ, Cooper PR. Growth factor release from dentine matrix by pulp capping agents promote pulp tissue repair-associated events. International endodontic journal. 2016. Epub 2016/02/26.
- 56. Mullaguri H, Suresh N, Surendran S, Velmurugan N, Chitra S. Role of pH Changes on Transforming Growth Factor-beta1 Release and on the Fibrin Architecture of Platelet-rich Fibrin When Layered with Biodentine, Glass Ionomer Cement, and Intermediate Restorative Material. Journal of endodontics. 2016;42(5):766–70. Epub 2016/04/10. pmid:27059650